Dr. Stella Sarraf founded Amydis in 2013 after seeing a clinical need for a novel technology for early detection of neurodegenerative diseases. She provides a unique blend of expertise in product development and commercialization, pharmaceutical operations, venture investment and entrepreneurship. Previously, Dr. Sarraf spent 10 years in venture capital at growth capital health care funds that manage more than $1 billion in assets. She led scientific, regulatory and commercial diligence on more than 400 investment opportunities from companies in developing therapeutics and diagnostics in areas including cognitive disorders and neurology. Earlier in her career, Dr. Sarraf worked at Merck Research Laboratories as a senior research chemist responsible for creating novel drugs. In 2016, she founded Spinogenix, Inc. focused on developing novel regenerative therapeutics. Dr. Sarraf holds a doctorate in organic chemistry from Columbia University and a bachelor's degree in biochemistry and molecular biology from